Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment: Erratum

Lymphoma
03/05/2020

[No authors listed] Medicine (Baltimore) 2020.

NO ABSTRACT